THE NOTES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED 
STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND MAY NOT 
BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) BY THE INITIAL 
INVESTOR (1) TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED 
INSTITUTIONAL BUYER (WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES 
ACT) PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED 
INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, 
(2) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT 
PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE), OR (3) PURSUANT TO AN 
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND (B) BY 
SUBSEQUENT INVESTORS, AS SET FORTH IN (A) ABOVE AND, IN ADDITION, TO AN 
INSTITUTIONAL ACCREDITED INVESTOR IN A TRANSACTION EXEMPT FROM REGISTRATION 
REQUIREMENTS OF THE SECURITIES ACT, IN EACH CASE (A) AND (B) IN ACCORDANCE 
WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES.




     THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE 
HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY (AS 
DEFINED IN THE INDENTURE) OR A NOMINEE THEREOF.  THIS NOTE IS EXCHANGEABLE 
FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS 
NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND, 
UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE 
FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO 
A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE 
DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY 
SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR 
DEPOSITARY.  

     UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE 
DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION, TO THE COMPANY (AS DEFINED 
BELOW) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND 
ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME 
AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY 
PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN 
AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER 
USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS 
THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

REGISTERED                    UNITED HEALTHCARE                  $
                                 CORPORATION                     CUSIP
NO.                    5.65% NOTES DUE DECEMBER 1, 1999          NO. 910581 AB 3



     UNITED HEALTHCARE CORPORATION, a Minnesota corporation (hereinafter 
called the "Company", which term includes any successor corporation under the 
Indenture referred to below), for value received, hereby promises to pay to 
CEDE & CO., or registered assigns, the principal sum of __________________ 
DOLLARS ($_____________) on December 1, 1999 (the "Stated Maturity"), and to 
pay interest thereon from __________________ or from the most recent date to 
which interest has been paid or duly provided for, semi-annually on June 1 
and December 1 in each year (each, an "Interest Payment Date"), commencing 
__________________ , and at Maturity, at the rate of 5.65% per annum, until 
the principal hereof is paid or duly made available for payment.  Interest on 
this Note shall be calculated on the basis of a 360-day year consisting of 
twelve 30-day months.  The interest so payable and punctually paid or duly 
provided for on any Interest Payment Date will, as provided in such 
Indenture, be paid to the Person in whose name this Note



(or one or more predecessor Notes) is registered at the close of business on 
the "Regular Record Date" for such interest, which shall be the May 15 or the 
November 15 (whether or not a Business Day) next preceding such Interest 
Payment Date; PROVIDED, HOWEVER, that interest payable at the Maturity of 
this Note shall be payable to the Person to whom principal shall be payable.  
Any such interest which is payable, but is not punctually paid or duly 
provided for, on any Interest Payment Date shall forthwith cease to be 
payable to the registered Holder hereof on the relevant Regular Record Date 
by virtue of having been such Holder, and may be paid (i) to the Person in 
whose name this Note (or one or more predecessor Notes) is registered at the 
close of business on a Special Record Date for the payment of such Defaulted 
Interest to be fixed by the Trustee, notice whereof shall be given to the 
Holder of this Note not less than 10 days prior to such Special Record Date 
or (ii) in any other lawful manner not inconsistent with the requirements of 
any securities exchange on which such Notes may be listed, and upon such 
notice as may be required by such exchange, if, after notice given by the 
Company to the Trustee of the proposed payment pursuant to this clause (ii), 
such manner of payment shall be deemed practicable by the Trustee.  In the 
event that any Interest Payment Date or date of Maturity is not a Business 
Day, the interest and, with respect to the date of Maturity, principal 
otherwise payable on such date will be paid on the next succeeding Business 
Day with the same force and effect as if made on such Interest Payment Date 
or on such date of Maturity.  "Business Day" shall mean any day that is not a 
Saturday or Sunday and that, in the City of New York, is not a day on which 
banking institutions are generally authorized or obligated by law to close.

     Payment of the principal of and the interest on this Note will be made 
at the office or agency of the Company maintained for that purpose in The 
City of New York, in such coin or currency of the United States of America as 
at the time of payment is legal tender for payment of public and private 
debts; PROVIDED, HOWEVER, that, at the option of the Company, interest may be 
paid by check mailed to the address of the Person entitled thereto as such 
address shall appear in the Security Register.   Payment of the principal of 
and interest on this Note due at Maturity will be made in immediately 
available funds upon presentation of this Note. 

     Reference is hereby made to the further provisions of this Note set 
forth on the reverse hereof, which further provisions shall for all purposes 
have the same effect as if set forth at this place.

     Unless the certificate of authentication hereon has been executed by or 
on behalf of the Trustee under the Indenture by the manual signature of one 
of its authorized signatories, this Note shall not be entitled to any 
benefits under the Indenture or be valid or obligatory for any purpose.




     IN WITNESS WHEREOF, the Company has caused this instrument to be duly 
executed.

Dated:  November 24, 1998



                                         UNITED HEALTHCARE CORPORATION



                                          By:      ____________________
                                          Name:    Allan J. Weiss
                                          Title:   Vice President and Treasurer



                                          Attest:  ____________________
                                          Name:    David J. Lubben
                                          Title:   General Counsel and Secretary


TRUSTEE'S CERTIFICATE OF
   AUTHENTICATION
                    

THIS IS ONE OF THE SECURITIES OF THE
SERIES DESIGNATED HEREIN AND ISSUED
PURSUANT TO THE WITHIN-MENTIONED
INDENTURE.

DATED:  NOVEMBER 24, 1998
                    
THE BANK OF NEW YORK, 
as Trustee


By:________________________
     Authorized Signatory




                         UNITED HEALTHCARE CORPORATION
                        5.65% NOTES DUE DECEMBER 1, 1999

                            [REVERSE SIDE OF NOTE]

     This Note is one of a duly authorized issue of securities of the Company 
(herein called the "Notes") issued and to be issued in one or more series 
under an Indenture dated as of  November 15, 1998, as supplemented pursuant 
to Section 301 thereof by the Officers' Certificate and Company Order dated 
November 24, 1998 (herein called, the "Indenture") between the Company and 
The Bank of New York, as Trustee (herein called the "Trustee", which term 
includes any successor trustee under the Indenture), to which Indenture and 
all indentures supplemental thereto reference is hereby made for a statement 
of the respective rights, limitations of rights, duties and immunities 
thereunder of the Company, the Trustee and the Holders of the Notes, and the 
terms upon which the Notes are, and are to be, authenticated and delivered.  
This Note is one of the series designated on the face hereof, limited in 
aggregate principal amount to $                        . 

REDEMPTION

     The Notes are not subject to redemption prior to the Stated Maturity.

MISCELLANEOUS PROVISIONS

     If an Event of Default with respect to the Notes shall occur and be 
continuing, the principal of the Notes may be declared due and payable in the 
manner and with the effect provided in the Indenture.

     The Indenture contains provisions for defeasance at any time of the 
Company's obligations in respect of (i) the entire indebtedness of this Note 
or (ii) certain restrictive covenants with respect to this Note, in each case 
upon compliance with certain conditions set forth therein.

     The Indenture permits, with certain exceptions as therein provided, the 
amendment thereof and the modification of the rights and obligations of the 
Company and the rights of the Holders of the Securities of each series issued 
under the Indenture at any time by the Company and the Trustee with the 
consent of the Holders of not less than a majority in aggregate principal 
amount of the Securities at the time Outstanding of each series affected 
thereby.  The Indenture also contains provisions permitting the Holders of 
specified percentages in aggregate principal amount of the Securities of any 
series at the time Outstanding to waive certain past defaults under the 
Indenture and their consequences.  Any such consent or waiver by the Holder 
of this Note shall be conclusive and binding upon such Holder and upon all 
future Holders of this Note and of any Notes issued upon the registration of 
transfer hereof or in exchange herefor or in lieu hereof, whether or not 
notation of such consent or waiver is made upon this Note.

     No reference herein to the Indenture and no provision of this Note or of 
the Indenture shall alter or impair the obligation of the Company, which is 
absolute and unconditional, to pay the principal of (and premium, if any) and 
interest on this Note, at the time, place and rate, and in the coin or 
currency, herein and in the Indenture prescribed.




     As provided in the Indenture and subject to certain limitations set 
forth therein and in this Note, the transfer of this Note is registrable in 
the registry books of the Company, upon surrender of this Note for 
registration of transfer at the office or agency of the Company maintained 
for the purpose in any place where the principal of (and premium, if any) and 
interest on this Note are payable, duly endorsed, or accompanied by a written 
instrument of transfer in form satisfactory to the Company and the Trustee 
duly executed by the Holder hereof or by his attorney duly authorized in 
writing, and thereupon one or more new Notes, of authorized denominations and 
for the same aggregate principal amount, will be issued to the designated 
transferee or transferees.

     The Notes of this series are issuable only in fully registered form 
without coupons in minimal initial purchase amounts of $100,000 and any 
amount in excess thereafter which is an integral multiple of $1,000.  As 
provided in the Indenture and subject to certain limitations therein set 
forth, Notes of this series are exchangeable for a like aggregate principal 
amount of Notes of this series and of like tenor of a different authorized 
denomination, as requested by the Holder surrendering the same.

     No service charge shall be made for any such registration of transfer or 
exchange, but the Company may require payment of a sum sufficient to cover 
any tax or other governmental charge payable in connection therewith, other 
than in certain cases provided in the Indenture.

     Prior to due presentment of this Note for registration of transfer, the 
Company, the Trustee and any agent of the Company or the Trustee may treat 
the Person in whose name this Note is registered as the owner hereof for all 
purposes, whether or not this Note be overdue, and neither the Company, the 
Trustee nor any such agent shall be affected by notice to the contrary.

     This Note shall be governed by and construed in accordance with the laws 
of the State of New York.

     All terms used in this Note which are defined in the Indenture shall 
have the meanings assigned to them in the Indenture.




                       ---------------------------------
                                ABBREVIATIONS

     The following abbreviations, when used in this instrument, shall be 
construed as though they were written out in full according to applicable 
laws or regulations:

     TEN COM--as tenants in common
     TEN ENT--as tenants by the entireties
     JT TEN--as joint tenants with right of survivorship
               and not as tenants in common
     UNIF GIFT MIN ACT--_______________Custodian_______________
                            (Cust)                  (Minor)

                        under Uniform Gift to Minors Act

                            _______________________
                                    (State)

Additional abbreviations may be used though not in the above list.

                       ---------------------------------




                                  ASSIGNMENT


     FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and
transfer(s) unto

PLEASE INSERT SOCIAL SECURITY NUMBER OR OTHER IDENTIFYING NUMBER OF ASSIGNEE

                  -------------------------------------------
                 |                                           |
                  -------------------------------------------

- ------

                 (Please print or typewrite name and address,
                    including postal zip code of assignee)


the within Note and all rights thereunder and hereby irrevocably constitutes 
and appoints _________________________________________ 


to transfer said Note on the books of the Company, with full power of
substitution in the premises.


Dated  _______________
                                       NOTICE: The signature on this assignment
                                       must correspond with the name as written
                                       upon the face of the within Note in every
                                       particular, without alteration or
                                       enlargement or any change whatsoever.


            Signature Guarantee


     SIGNATURE GUARANTEE: Signatures must be guaranteed by an "eligible 
institution" meeting the requirements of the [Registrar], which requirements 
include membership or participation in the Security Transfer Agent Medallion 
Program ("STAMP") or such other "signature guarantee program" as may be 
determined by the [Registrar] in addition to, or in substitution for, STAMP, 
all in accordance with the Securities Exchange Act of 1934, as amended.

                           CERTIFICATE OF TRANSFER




     In connection with any transfer of this Note occurring prior to the date 
that is two years after the later of November 24, 1998 and the last date on 
which this Note (or any predecessor Note) was owned by the Company or any 
affiliate of the Company, the undersigned confirms that this Note is being 
transferred:

CHECK ONE BOX BELOW
    ___   (a)       As long as this Note is eligible for resale pursuant to Rule
          144A under the Securities Act of 1933, as amended, to a person the
          undersigned reasonably believes is a "qualified institutional buyer"
          (a "QIB") as defined in such Rule 144A that purchases for its own
          account or for the account of a QIB to whom notice is given that the
          transfer is being made in reliance on such Rule 144A;

    ___   (b)       to an institutional "accredited investor" (as defined in
          Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933, as
          amended) that has furnished to the Trustee a signed letter containing
          certain representations and agreements (the form of which letter can
          be obtained from the Trustee); or 

    ___   (c)       pursuant to an exemption from registration under the
          Securities Act of 1933, as amended, pursuant to Rule 144 thereunder;
          or

    ___   (d)  to the Company.


     Unless the certificate of authentication hereon has been executed by or 
on behalf of the Trustee under the Indenture by the manual signature of one 
of its authorized signatories, this Note shall not be entitled to any 
benefits under the Indenture or be valid or obligatory for any purpose.


Dated:________________



                             SIGNATURE



Signature Guaranteed:



                             SIGNATURE



             TO BE COMPLETED BY PURCHASER IF (a) ABOVE IS CHECKED.


     The undersigned represents and warrants that it is acquiring this Note for
its own account or an account with respect to which it exercises sole investment
discretion and that it or any such account , as the case may be, is a "qualified
institutional buyer" within the meaning of Rule 144A under the Securities Act of
1933, as amended, and is aware that the sale to it is being made in reliance on
Rule 144A and acknowledges that it has received such information regarding the
Company as the undersigned has requested pursuant to Rule 144A or has determined
not to request such information and that it is aware that the transferor is
relying upon the undersigned's foregoing representations in order to claim the
exemption from registration provided by Rule 144A.


Dated:______________________


NOTICE:  To be executed by an executive officer